Ann Arbor’s Terumo Cardiovascular Partners with Boston Firm on Cardiac Monitoring

Terumo Cardiovascular Group, an Ann Arbor company that provides cardiovascular surgery technologies, is collaborating with Boston clinical software developer Etiometry to bring advanced clinical decision support to adult cardiac surgery patients during surgery and recovery.
16
Terumo Cardiovascular Group is collaborating with Etimetry to bring advanced clinical decision support to adult cardiac surgery patients. // Courtesy of Etiometry
Terumo Cardiovascular Group is collaborating with Etimetry to bring advanced clinical decision support to adult cardiac surgery patients. // Courtesy of Etiometry

Terumo Cardiovascular Group, an Ann Arbor company that provides cardiovascular surgery technologies, is collaborating with Boston clinical software developer Etiometry to bring advanced clinical decision support to adult cardiac surgery patients during surgery and recovery.

The partnership will pair Etiometry’s platform, which helps clinicians better manage patient data and provides actionable information in intensive care settings, with Terumo’s cardiac surgical devices to bring deeper understanding and enhanced perioperative management of a patient’s condition.

“Health care systems are looking for solutions to improve care coordination and decision-making while reducing the overall cost of care,” says Robert DeRyke, president and CEO of Terumo Cardiovascular. “Our collaboration with Etiometry addresses these challenges by developing a digital solution that combines clinical workflow with clinical decision support for the acute care hospital setting. The Etiometry data and analytics platform provides clinicians with insights that can help improve overall quality of care for cardiac surgery patients.”

The Etiometry platform collects data that indicates the likelihood a patient will experience an adverse medical event. It can automate and deploy enhanced recovery after surgery (ERAS) protocols for the management of cardiac surgery patients throughout their hospital stay. The increased patient surveillance available with the platform brings improved detection and management of potential complications associated with cardiac surgery.

Terumo Cardiovascular manufactures a wide range of products for cardiac and vascular procedures, offering a full line of perfusion products, endoscopic vessel harvesting products, and surgical stabilization products.

“Expanding our technologies and partnering with Terumo allows for our clinical decision-support tools to be utilized across the spectrum of a patient’s hospital stay,” says Shane Cooke, CEO of Etiometry. “Having a more holistic view of critical data as a patient moves from the operating room to the ICU is imperative to improving outcomes for these complex clinical circumstances. The collaboration of our organizations will bring this opportunity to many more patients for improved and more informed bedside decisions.”

Facebook Comments